Logo image of TNMG

TNL MEDIAGENE (TNMG) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TNMG - KYG8924F1054 - Common Stock

0.21 USD
+0.01 (+2.74%)
Last: 12/16/2025, 12:50:11 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TNMG. TNMG was compared to 95 industry peers in the Media industry. Both the profitability and financial health of TNMG have multiple concerns. TNMG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TNMG had negative earnings in the past year.
TNMG had a negative operating cash flow in the past year.
In multiple years TNMG reported negative net income over the last 5 years.
TNMG had a negative operating cash flow in each of the past 5 years.
TNMG Yearly Net Income VS EBIT VS OCF VS FCFTNMG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

TNMG has a Return On Assets of -91.43%. This is amonst the worse of the industry: TNMG underperforms 84.21% of its industry peers.
TNMG has a Return On Equity of -233.38%. This is in the lower half of the industry: TNMG underperforms 78.95% of its industry peers.
Industry RankSector Rank
ROA -91.43%
ROE -233.38%
ROIC N/A
ROA(3y)-28.56%
ROA(5y)N/A
ROE(3y)-75.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TNMG Yearly ROA, ROE, ROICTNMG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

Looking at the Gross Margin, with a value of 36.58%, TNMG is in line with its industry, outperforming 47.37% of the companies in the same industry.
TNMG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TNMG Yearly Profit, Operating, Gross MarginsTNMG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

1

2. Health

2.1 Basic Checks

TNMG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TNMG remains at a similar level compared to 1 year ago.
Compared to 1 year ago, TNMG has a worse debt to assets ratio.
TNMG Yearly Shares OutstandingTNMG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
TNMG Yearly Total Debt VS Total AssetsTNMG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

A Debt/Equity ratio of 0.16 indicates that TNMG is not too dependend on debt financing.
TNMG has a Debt to Equity ratio of 0.16. This is in the better half of the industry: TNMG outperforms 70.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.07%
TNMG Yearly LT Debt VS Equity VS FCFTNMG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.54 indicates that TNMG may have some problems paying its short term obligations.
The Current ratio of TNMG (0.54) is worse than 82.11% of its industry peers.
A Quick Ratio of 0.53 indicates that TNMG may have some problems paying its short term obligations.
With a Quick ratio value of 0.53, TNMG is not doing good in the industry: 82.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.53
TNMG Yearly Current Assets VS Current LiabilitesTNMG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

TNMG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10553.80%.
TNMG shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.31%.
EPS 1Y (TTM)-10553.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.17%
Revenue 1Y (TTM)35.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.72%

3.2 Future

The Earnings Per Share is expected to grow by 41.42% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 24.40% on average over the next years. This is a very strong growth
EPS Next Y92.72%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.35%
Revenue Next 2Y24.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

TNMG Yearly Revenue VS EstimatesTNMG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 20M 40M 60M
TNMG Yearly EPS VS EstimatesTNMG Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

TNMG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNMG Price Earnings VS Forward Price EarningsTNMG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNMG Per share dataTNMG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

TNMG's earnings are expected to grow with 41.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TNMG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

TNL MEDIAGENE

NASDAQ:TNMG (12/16/2025, 12:50:11 PM)

0.21

+0.01 (+2.74%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.13%
Inst Owner ChangeN/A
Ins Owners20.51%
Ins Owner ChangeN/A
Market Cap8.68M
Revenue(TTM)48.49M
Net Income(TTM)-84.95M
Analysts82.86
Price Target3.57 (1600%)
Short Float %4.01%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-92.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B 0.24
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.51
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS1.17
BVpS0.88
TBVpS-0.69
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -91.43%
ROE -233.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.58%
FCFM N/A
ROA(3y)-28.56%
ROA(5y)N/A
ROE(3y)-75.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 253.36%
Cap/Sales 17.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.53
Altman-Z N/A
F-Score3
WACC6.07%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10553.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.17%
EPS Next Y92.72%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.72%
Revenue Next Year22.35%
Revenue Next 2Y24.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-566.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2793.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1561.7%
OCF growth 3YN/A
OCF growth 5YN/A

TNL MEDIAGENE / TNMG FAQ

Can you provide the ChartMill fundamental rating for TNL MEDIAGENE?

ChartMill assigns a fundamental rating of 2 / 10 to TNMG.


Can you provide the valuation status for TNL MEDIAGENE?

ChartMill assigns a valuation rating of 1 / 10 to TNL MEDIAGENE (TNMG). This can be considered as Overvalued.


How profitable is TNL MEDIAGENE (TNMG) stock?

TNL MEDIAGENE (TNMG) has a profitability rating of 1 / 10.


What is the financial health of TNL MEDIAGENE (TNMG) stock?

The financial health rating of TNL MEDIAGENE (TNMG) is 1 / 10.